September 1, 2021Cancer/testis antigen expression landscape in gastroesophageal adenocarcinoma Read more »
April 2, 2022Cancer testis antigen burden: pan-cancer distribution and survival implications Read more »
September 30, 2021Aligning Tumor Mutational Burden (TMB) quantification across diagnostic platforms: Phase 2 of the Friends of Cancer Research TMB Harmonization Project Read more »
July 1, 2022LAG3 transcriptomic expression correlates with high levels of PD-1, PD-L1, PD-L2, and CTLA-4 checkpoints and with high tumor mutational burden across cancers Read more »
March 4, 2021T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors Read more »
October 18, 2022Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor response in metastatic renal cell carcinoma Read more »
April 17, 2023Ultra-deep targeted sequencing of cell-free DNA and patient-matched white blood cells for treatment response evaluation in patients with metastatic colorectal cancer Read more »
